ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3
Go back to ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) | Delayed: 0.87 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.87 | 52 Week High | $13.74 | |||
Open | $0.87 | 52 Week Low | $4.45 | |||
Day High | $0.87 | P/E | N/A | |||
Day Low | $0.87 | EPS | $-0.95 | |||
Volume | 2,400 |